Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Trading Update

11 Feb 2015 08:05

RNS Number : 6075E
Imaginatik PLC
11 February 2015
 

11 February 2015

Imaginatik Plc

 

("Imaginatik" or "the Company")

 

Trading Update

 

 

Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offering a range of consultancy and technology products, provides a trading update covering the second half of the Company's financial year to date.

 

As announced in the Interim Results on 8 December 2014, trading continues to progress well and in line with management expectations. Approximately £1.2m of new and upsell business has been contracted so far in the second half, including seven new customers; four on annual or multi-year contracts and three on consulting engagements.

 

The addition of the four new customers on annual or multi-year contracts in our second half takes the Company's annual client base to 41 (March 2014: 31) raising the annualised value of our renewals business by 20% to £2.96m (March 2014: £2.48m at constant currency). We are currently in contract discussions with a number of other companies and expect to complete several new contracts in the next few weeks, all of which will further add to our customer and renewals base.

 

We are also pleased to report good progress being made in the Consulting division. In addition to the three new consulting customers referred to above, we have expanded contracts with several existing customers to provide a range of consulting engagements that encompass consulting support work with our Innovation Central technology platform, Discovery work with our Discovery Central technology tool as well as more strategic advice on innovation.

 

Matt Cooper, Non-Executive Chairman, commented "The Board is pleased with the progress the company is making. The size and quality of the client base is increasing, as is the recurring revenue base, which is bringing greater visibility and demonstrating that our business model is working. As we continue to build our new business pipeline there is a growing requirement for additional capital to fund the protracted lead time from first engagement to signed contract. Accordingly the Company will continue to carefully manage its cash reserves and will be considering its various funding options to ensure that the business maintains sufficient levels of investment during this early growth phase".

 

 

 

 

For further information please contact:

 

Imaginatik plc

Tel: 01329 243 243

Matt Cooper Non-Executive Chairman

Ralph Welborn, CEO

Shawn Taylor, CFO

finnCap Ltd

Tel: 020 7220 0500

Charlotte Stranner / Victoria Bates

Newgate Threadneedle

Tel: 020 7653 9850

Adam Lloyd / Ed Treadwell / Jasper Randall

 

About Imaginatik

 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, The Chubb Group of Insurance Companies, , Exxon Mobil, Altria, Shell, Mayo Clinic, Goodyear, the Yorkshire Building Society, Pitney Bowes and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Fareham, UK. For more information visit www.imaginatik.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUCUPUPAURG
Date   Source Headline
9th Jun 201710:54 amRNSProposed Placing
27th Apr 20177:00 amRNSChange of Registered Office
25th Apr 20177:00 amRNSTrading Update
24th Apr 20178:16 amRNSHolding(s) in Company
27th Feb 201710:35 amRNSHolding(s) in Company
14th Dec 20169:31 amRNSHolding(s) in Company
9th Dec 201611:47 amRNSHolding(s) in Company
6th Dec 20167:00 amRNSHalf-year Report
25th Nov 20169:56 amRNSHolding(s) in Company
24th Nov 20167:00 amRNSTrading Update and Notice of Results
13th Sep 20162:29 pmRNSResult of AGM
13th Sep 20167:00 amRNSGrant of Options
17th Aug 20167:00 amRNSFinal Results
10th Aug 20163:21 pmRNSHolding(s) in Company
21st Jul 20164:46 pmRNSHolding(s) in Company
28th Jun 201612:12 pmRNSHolding(s) in Company
27th Jun 201611:45 amRNSHolding(s) in Company
24th Jun 20167:00 amRNSResult of Open Offer and Total Voting Rights
16th Jun 201610:35 amRNSHolding(s) in Company
13th Jun 201611:20 amRNSResult of General Meeting
25th May 20167:00 amRNSFundraising
17th May 201612:26 pmRNSFunding Update
17th May 201610:51 amRNSPress Speculation
29th Apr 20169:09 amRNSHolding(s) in Company
28th Apr 201610:54 amRNSHolding(s) in Company
27th Apr 20169:04 amRNSHolding(s) in Company
13th Apr 20161:36 pmRNSHolding(s) in Company
12th Apr 201610:18 amRNSHolding(s) in Company
6th Apr 20164:51 pmRNSHolding(s) in Company
6th Apr 20161:23 pmRNSPress Speculation
9th Mar 20167:00 amRNSTrading Update
26th Jan 201610:03 amRNSHolding(s) in Company
21st Jan 20162:51 pmRNSHolding(s) in Company
5th Jan 20167:00 amRNSDirector Loan
17th Dec 20158:20 amRNSHolding(s) in Company
15th Dec 20157:00 amRNSGrant of Options
10th Dec 20157:00 amRNSHalf Yearly Report
13th Nov 20153:35 pmRNSWarrant Exercise
9th Nov 20153:57 pmRNSTrading update
6th Nov 20154:13 pmRNSHolding(s) in Company
23rd Sep 20153:07 pmRNSResult of AGM
16th Sep 20157:00 amRNSDirector Loan
14th Sep 20155:33 pmRNSHolding(s) in Company
1st Sep 20154:34 pmRNSNotice of AGM
1st Sep 20152:23 pmRNSHolding(s) in Company
24th Aug 20157:00 amRNSHolding(s) in Company
10th Aug 20152:20 pmRNSHolding(s) in Company
6th Aug 20151:41 pmRNSHolding(s) in Company
3rd Aug 201512:05 pmRNSHolding(s) in Company
30th Jul 20151:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.